Importantly, Retatrutide's unique triple receptor agonismtargeting GLP-1, GIP, and glucagon receptorsappears well-tolerated, with adverse events largely consistent with known effects from the broader GLP-1 class, primarily mild gastrointestinal symptoms such as nausea, decreased appetite, and occasional diarrhea, typically resolving within a few weeks of initiation
NOTA DESTACADA DE CORREO FARMACUTICO: En la Argentina, la indicacin de semaglutida sigue siendo para personas adultas con diabetes tipo 2, que tienen obesidad y riesgo cardiovascular, explica la Dra
The benefits of tirzepatide beyond weight loss stem in large part from these downstream GLP-1R effects
Users who maintain muscle mass report better energy levels, easier daily activities, and less of the fatigue that GLP-1 users commonly experience
Aim for at least 25-30 grams of fiber each day
Implications of glucocorticoid therapy in idiopathic inflammatory myopathies